GENEVA, March 23 -- CHENGDU RONGSHENG PHARMACEUTICALS CO., LTD (No. 7 Keyuan South Road, Qibuyuan, High-tech ZoneChengdu, Sichuan 610041), 成都蓉生药业有限责任公司 (中国四川省成都市高新区起步园科园南路7号) filed a patent application (PCT/CN2024/095207) for "HUMANIZED NANOBODY AGAINST TGFBeta" on May 24, 2024. With publication no. WO/2025/055383, the details related to the patent application was published on Mar 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World In...